3-[1-(二甲基氨基)乙基]苯酚 | 105601-04-5

• 物质功能分类: 化学试剂 - 有机试剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 3-[1-(二甲基氨基)乙基]苯酚
• 中文别名: 3-[1-(二甲氨基)乙基]苯酚；3-[1-（二甲基氨基）乙基]苯酚；二甲基氨基乙基苯酚；卡巴拉汀(利斯的明)中间体；3-[1-(N,N-二甲胺基)乙基]苯酚；卡巴拉汀中间体2；3-(1-(二甲基氨基)乙基)苯酚
• 英文名称: 3-(1-(dimethylamino)ethyl)phenol
• 英文别名: (±)-3-(1-(dimethylamino)ethyl)phenol；3-[1-(Dimethylamino)ethyl]phenol
• CAS: 105601-04-5
• 化学式: C₁₀H₁₅NO
• 分子量: 165.235
• InChiKey: GQZXRLWUYONVCP-UHFFFAOYSA-N

物化性质

• 熔点：
  87-89°C
• 沸点：
  241℃
• 密度：
  1.021
• 闪点：
  97℃
• 溶解度：
  溶于甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  T
• 安全说明：
  S26,S39,S45
• 危险类别码：
  R25,R41
• 包装等级：
  III
• 危险类别：
  8,6.1
• 危险性防范说明：
  P273,P280,P301+P310,P305+P351+P338,P310
• 危险品运输编号：
  2923
• 危险性描述：
  H301,H318,H412
• 储存条件：
  -20°C 冰箱

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-[1-(Dimethylamino)ethyl]phenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H301: Toxic if swallowed
H318: Causes serious eye damage
H412: Harmful to aquatic life with long lasting effects
P273: Avoid release to the environment
P280: Wear protective gloves/protective clothing/eye protection/face protection
P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-[1-(Dimethylamino)ethyl]phenol
CAS number: 105601-04-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H15NO
Molecular weight: 165.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (3-[1-(Dimethylamino)ethyl]phenol)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

制备方法

卡巴拉汀中间体。

用途简介

（该部分暂无内容）

反应信息

• 作为反应物：
  描述：

  3-[1-(二甲基氨基)乙基]苯酚 在 D(+)-10-樟脑磺酸 作用下， 以 乙醇 、 乙酸乙酯 为溶剂， 反应 0.67h， 以33.8%的产率得到3-(1-(S)-(N,N-二甲基氨基)乙基)苯酚
  参考文献：
  名称：

  一种重酒石酸卡巴拉汀的制备方法

  摘要：

  本发明公开了一种重酒石酸卡巴拉汀的制备方法，以(R,S)‑3‑(1‑(二甲氨基)乙基)苯酚为原料，用S‑(+)‑樟脑磺酸拆分后，得到对映纯的(S)‑3‑(1‑(二甲氨基)乙基)苯酚；再与N‑乙基‑N‑甲基氨基甲酰氯对接得到卡巴拉汀游离碱，最后与L‑(+)‑酒石酸成盐得到重酒石酸卡巴拉汀。通过对原料合成过程进行处理，中间体精制中利用酸碱交替除杂，以及后期纯化用丙酮打浆等工艺控制，得到一种制备重酒石酸卡巴拉汀的方法，本方法不仅提高了产品纯度和收率，使异构体杂质更能有效控制，而且大大降低成本，简化工艺，更适合工业化生产。

  公开号：

  CN106565543B
• 作为产物：
  描述：

  1-(3-羟基苯基)乙醇 在 氯化亚砜 、 potassium carbonate 、 potassium iodide 、 potassium hydroxide 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 4.5h， 生成 3-[1-(二甲基氨基)乙基]苯酚
  参考文献：
  名称：

  2,4-双取代苯乙酮化合物及其旋光异构体、药 学上可接受的盐及应用

  摘要：

  本发明涉及一种2,4‑双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐。本发明还公开了2,4‑双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐在治疗神经变性疾病方面的应用，该类新化合物不仅具有乙酰胆碱酯酶抑制活性和Aβ聚集抑制能力，其水解产物还具有金属离子螯合作用，可以从多个靶点进行治疗，具有较好的神经变性疾病应用前景。

  公开号：

  CN107417574B

文献信息

• SYNTHESIS OF NOVEL INTERMEDIATE(S) FOR PREPARING RIVASTIGMINE
  申请人：Cadila Pharmaceuticals Ltd.

  公开号：US20200095195A1

  公开（公告）日：2020-03-26

  The present invention relates to novel intermediate(s), which are useful for the preparation of Rivastigmine compound of formula (I) and its pharmaceutically acceptable salts. The present invention further relates to the processes for the preparation of such novel intermediate(s) and preparation of Rivastigmine using such novel intermediate(s).

  本发明涉及新型中间体，该中间体对于制备化合物Rivastigmine的公式（I）及其药用可接受的盐是有用的。本发明还涉及制备这种新型中间体的方法以及使用这种新型中间体制备Rivastigmine的方法。
• PREPARATION METHOD FOR RIVASTIGMINE, INTERMEDIATES THEREOF, AND PREPARATION METHOD FOR SAID INTERMEDIATES
  申请人：Zhang Fuli

  公开号：US20140073809A1

  公开（公告）日：2014-03-13

  The present invention provides the preparation method for (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (formula X compound), the preparation methods for its intermediates (S)-1-(3-methoxyphenyl)-N,N-dimethyl-N—((S)-1-phenylethyl)ethanaminium (formula VI compound), (S)-1-(3-hydroxyphenyl)-N,N-dimethyl-N—((S)-1-phenylethyl)ethanaminium (formula VIII compound) and (S)-1-(3-(ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethyl-N—((S)-1-phenylethyl)ethanaminium (formula IX compound), as well as the method for using above mentioned formula IX compound to prepare rivastigmine which can be used for the treatment of Alzheimer's disease. The preparation method for rivastigmine has a reasonable synthetic design with convenient source of raw materials and high total yield, and the product resulted has high chemical and optical purity, which makes it easy for large-scale. industrial production.

  本发明提供了(S)-3-(1-(二甲基氨基)乙基)苯基乙基(甲基)氨基甲酸酯（化合物X的结构）的制备方法，以及其中间体(S)-1-(3-甲氧基苯基)-N,N-二甲基-N-((S)-1-苯乙基)乙胺盐（化合物VI的结构）、(S)-1-(3-羟基苯基)-N,N-二甲基-N-((S)-1-苯乙基)乙胺盐（化合物VIII的结构）和(S)-1-(3-(乙基(甲基)氨基甲酰氧基)苯基)-N,N-二甲基-N-((S)-1-苯乙基)乙胺盐（化合物IX的结构）的制备方法，以及利用上述化合物IX制备利伐替林的方法，利伐替林可用于治疗阿尔茨海默病。利伐替林的制备方法具有合理的合成设计，原料来源便利，总产率高，所得产品具有高化学和光学纯度，便于大规模工业生产。
• PREPARATION OF RIVASTIGMINE AND ITS SALTS
  申请人：Mandava Venkata Naga Brahmeswara Rao

  公开号：US20080255383A1

  公开（公告）日：2008-10-16

  There are provided processes for making rivastigmine. In one embodiment, the process includes reacting S-(−)-[1-(3-hydroxyphenyl)ethyl]dimethylamine with N-ethyl-N-methyl carbamoyl chloride in the presence of an organic base to obtain a free base of rivastigmine.

  提供了制备利他林的过程。在一个实施例中，该过程包括在有机碱的存在下，将S-(−)-[1-(3-羟基苯基)乙基]二甲基胺与N-乙基-N-甲基氨基甲酰氯反应，以获得利他林的自由碱。
• Methyl‐Selective α‐Oxygenation of Tertiary Amines to Formamides by Employing Copper/Moderately Hindered Nitroxyl Radical (DMN‐AZADO or 1‐Me‐AZADO)
  作者：Satoru Nakai、Takafumi Yatabe、Kosuke Suzuki、Yusuke Sasano、Yoshiharu Iwabuchi、Jun‐ya Hasegawa、Noritaka Mizuno、Kazuya Yamaguchi

  DOI：10.1002/anie.201909005

  日期：2019.11.11

  α-oxygenation of tertiary amines by employing a Cu/nitroxyl radical catalyst system. The use of moderately hindered nitroxyl radicals, such as 1,5-dimethyl-9-azanoradamantane N-oxyl (DMN-AZADO) and 1-methyl-2-azaadamanane N-oxyl (1-Me-AZADO), was very important to promote the oxygenation effectively mainly because these N-oxyls have longer life-times than less hindered N-oxyls. Various types of tertiary N-methylamines

  叔胺的甲基选择性α-加氧是合成甲酰胺同时保留胺底物骨架的极具吸引力的方法。因此，开发能够使用分子氧（O 2）作为末端氧化剂来促进在N-甲基位置上的区域选择性α-氧化的有效催化剂是重要的课题。在这项研究中，我们成功地通过使用Cu / nitroxyl自由基催化剂系统开发了一种高度区域选择性和高效的叔胺好氧甲基选择性α-加氧方法。使用中等受阻的硝酰基自由基，例如1,5-二甲基-9-金刚烷金刚烷N-氧基（DMN-AZADO）和1-甲基-2-氮杂金刚烷N-氧基（1-Me-AZADO）对于有效地促进氧合作用，主要是因为这些N-羟基比受阻较少的N-羟基具有更长的寿命。将各种类型的叔N-甲胺选择性地转化为相应的甲酰胺。还根据实验证据以及DFT计算讨论了合理的反应机理。该催化剂体系的高区域选择性源自胺-N-氧基相互作用的空间限制。
• Cyclische Phenyl-carbamate des Miotin-Typs und ihre Wirkung auf die Acetylcholinesterase
  作者：Ren� Amstutz、Albert Enz、Martin Marzi、Jakob Boelsterli、Malcolm Walkinshaw

  DOI：10.1002/hlca.19900730323

  日期：1990.5.2

  Cyclic Phenyl Carbamates and Their Action on Acetylcholinesterase

  环状苯基氨基甲酸酯及其对乙酰胆碱酯酶的作用